Highlights the need for an evidence-based approach to managing the growing population of elderly patients with von Willebrand Disease, who face unique challenges with comorbidities and antithrombotic therapies.
No takes yet. Share an insight, caveat, or question.
May warrant cautious antithrombotic decisions in ageing vWD; leaves open prospective trials for evidence-based guidelines.
Miesbach et al. (2011) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: